3Saitoh O, Kojima K, Kayazawa M, et al. Comparison of tests for fecal lactofcrrin and fecal occult blood for colorectal diseases: a prospective pilot study [ J]. Intern Med, 2000,39(10) :778-782.
4Young GP, St John D J, Winawer SJ, et al. Choice of fecal ooeult blood tests for colorectal cancer screening: recommandations based on performance characteristies in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy ) report [ J ]. AM J Gastroenterel, 2002,97 (10) :2499-2507.
5Mare A, Sinatra D, James B, et al. Interference of plant peroxidase with guaiac-based fecal occult blood tests is avoidable [ J ]. Clin Chem, 1999,45( 1 ) :123-126.
2Nakama H. Xhang B, Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer[J]. Dig Dis Sci,2000,Nov,45(11):.2195～2198.
4Young GP,St John DJ,Winawer SJ,et al.Choice of fecal occult blood tests for colorectal caner screening:recommendations based on performance characteristics in population studies:a WHO (World Health Organization) and OMED (World Organization for Digestive Endosocopy) report[J].AM J Gastroenterol,2002,97(10):2499-2507.
5Barry MJ.Fecal occult blood testing for colorectal cancer:a perspective[J].Ann Oncol,2002,13(1):61-64.
6Nakama H,Kamijo N,Miyata K,et al.Sensitivity and specificity of several immunochemical tests for colorectal cancerUJ.Hepatogastroenterology,1998,45(23):1579-1582.
7Nakama H,Zhang B.Immunochemical fecal occult blood test is inadequate for screening test of stomach caner[J].Dig Dis Sci,2000,45(11):2195-2198.
8Nakama H,Kamijo N,Fattah AS,et al.Immunologic detection of fecal occult blood from upper digestive tract diseases[J].Hepatogastroenterology,1998,45(21):752-754.
10Saitoh 0,Kojima K,Kayazawa M,et al.Comparison of tests for fecal lactoferrin and fecal occult blood for colorectal diseases:a prospective pilot study[J].Intern Med,2000,39 (10):778-782.
7M.J. Duffy,R. Lamerz,C. Haglund,A. Nicolini,M. Kalousová,L. Holubec,C. Sturgeon.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update[J]. Int. J. Cancer . 2014 (11)
8Koga Yoshikatsu,Yasunaga Masahiro,Moriya Yoshihiro,Akasu Takayuki,Fujita Shin,Yamamoto Seiichiro,Baba Hideo,Matsumura Yasuhiro.Detection of the DNA point mutation of colorectal cancer cells isolated from feces stored under different conditions. Japanese journal of clinical oncology . 2008
9Hardt Philip D,Ewald Nils.Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Expert review of molecular diagnostics . 2008
10Ewald Nils,Schaller Markus,Bayer Martin,Akinci Ahmet,Bretzel Reinhard G,Kloer Hans-Ulrich,Hardt Philip D.Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer. Anticancer Research . 2007
